Emerging Biotech Selects Synchrogenix, a Certara Company as Transparency & Disclosure Provider

Emerging Biotech Selects Synchrogenix, a Certara Company as Transparency & Disclosure Provider

In early 2020, an emerging global biotechnology company was in need of anonymization and redaction services for upcoming expected Health Canada approvals. They engaged Synchrogenix, Certara’s Regulatory Sciences division, to prepare the company’s first ever redaction filings in 2021. In the interim, due to internal growth, the company found itself needing additional transparency & disclosure services, including protocol registrations and clinical trial results postings. The company also required the authoring of plain language summaries.

Logo